Etiology, pathopysiology and treatment of NK cell-lineage leukemias and lymphomas
Etiology, pathopysiology and treatment of NK cell-lineage leukemias and lymphomas
批准号:
07457234
负责人:
OSHIMI Kazuo
金额:
$4.86万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. Infection of Epstein-Barr virus (EBV) in NK cells.From the studies of cases of NK cell disorders, EBV was considered to be the etiologic agentin aggressive-type NK-GLPD and NK-cell lymphomas. In indolent-type NK-GLPD,however, EBV seemed to be unrelated to the disorder.2. Characterization of NK cells in various types of NK-cell disorders.NK cells obtained from patients with various types of NK-cell disorders were studied in terms of surface phenotype, cell lineage, developmental stage, cytotoxicity, and T-cell receptor (TCR) and IgH genes. In nasal NK-cell lymphoma, malignant NK cells seemed to be activated mature NK cells, but not to be immature NK cells. In NK-GLPD,it is uncertain whether NK cells of aggressive-type NK-GLPD are immature cell sor activated mature NK cells, and NK cells of indolent-type NK-GLPD were found to be activated mature NK cells.3. Expression of multidrug resistance (MDR) 1-coded P-glycoprotein (P-gp) on NK cellsNK cells including normal NK cells, nasal NK lymphoma cells, aggressive type NK-GLPD cells, indolent-type NK-GLPD cells, and two NK-cell lines were tested fortheir expression of P-gp. Except one NK-cell line, all the NK cells tested were found to express P-gp. Further, the function of P-gp was inhibited by the addition of cyclosporin A and its derivative PSC833. Because of these in vitro study of these drugs on P-gp function, their in vivo function must be delineated.4. Transformation of NK cells with EBVIn vitro transformation of NK cells with EBV has been tried. A preliminary study indicates the possible infection of EBV into normal NK cells and a NK cell line. Now the finding is being confirmed by other techniques.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kaneko T et al.: "Nasal natural Killer(NK) cell lymphoma : report of a case with activated NK cells contairing Epsteim-Barr virus and・・・" British Jounal of Haematology. 91. 355-361 (1995)
Kaneko T 等人:“鼻自然杀伤 (NK) 细胞淋巴瘤:含有 Epsteim-Barr 病毒的活化 NK 细胞病例报告和……”英国血液学杂志 91. 355-361 (1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Semenzato G et al.: "The lymphoprobiferative disease of……" Blood. 63. 256-260 (1997)
Semenzato G 等人:“……的淋巴组织增生性疾病”,《血液》63. 256-260 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Oshimi K: "Lymphoprolif erative disorders of natural killer cells." Int J Hematol. 63. 279-290 (1996)
Oshimi K:“自然杀伤细胞的淋巴增殖性疾病。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Semenzato G,Zambello R,Starkebaum G,Oshimi K,Loughran TP: "The lymphoprolif erative disorders of granular lymphocytes : updated criteria for diagnosis." Blood. 89. 256-260 (1997)
Semenzato G,Zambello R,Starkebaum G,Oshimi K,Loughran TP:“颗粒淋巴细胞的淋巴增殖性疾病:更新的诊断标准。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Oshimi K: "Lymphoproliferative disorders of natural……" Int J Hematol. 63. 279-290 (1996)
Oshimi K:“自然淋巴增殖性疾病……”Int J Hematol 63. 279-290 (1996)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Induction of specific cytotoxicity for autologous leukemic cells by the use of keller T cells and bispecific antibodies
-
批准号:02454522
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.3万
-
财政年份:1990
-
负责人:OSHIMI Kazuo
-
依托单位:
Morphology and function of lymphocytes expanded in granular lymphocyte leukemia
-
批准号:63480280
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.52万
-
财政年份:1988
-
负责人:OSHIMI Kazuo
-
依托单位:
IL-2-activated lymphocytes lytic for autologous leukemia and lymphoma cells: some problems on their clinical application.
-
批准号:61480262
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.37万
-
财政年份:1986
-
负责人:OSHIMI Kazuo
-
依托单位:
海外基金